Clicky

Tuesday, October 27, 2026

Companies

Public company updates

Lindsay Corporation announces Q4 results, new incentive plan

Lindsay Corporation reports Q4 results and unveils a new management incentive plan for fiscal 2027, impacting the farm machinery and equipment industry.

Insteel Industries reports Q4 and fiscal year results

Insteel Industries Inc. reports lower Q4 earnings but higher sales, announces consolidation of operations amid inflationary pressures.

Lazard reports strong Q3 2026 results, revenue growth evident

Lazard, Inc. announces third-quarter 2026 financial results, showcasing strong revenue growth and strategic advancements in investment advice.

Varex Imaging Advances Merger with Teledyne Amid Lawsuits

Varex Imaging Corp is advancing its merger with Teledyne Technologies despite shareholder lawsuits challenging the deal. A special meeting is set for October 28.

Heritage Financial reports Q3 results, declares cash dividend

Heritage Financial Corp announces Q3 results with $18.7 million net income and declares a $0.25 cash dividend per share, reflecting stability in the sector.

TruGolf regains Nasdaq compliance after Polymath acquisition

TruGolf Holdings, Inc. regains compliance with Nasdaq's equity requirement after acquiring Polymath Research Inc., impacting the sporting goods industry.

H.B. Fuller issues $850 million in new notes for acquisition

H.B. Fuller Company has issued $850 million in new notes to enhance financial flexibility ahead of a major acquisition.

Artificial Intelligence Technology Solutions Secures New Orders

AITX announces new orders for its AI-driven security products, signaling growth and increased acceptance in the prepackaged software industry.

TTM Technologies Posts Record Q3 Results and Expands Acquisitions

TTM Technologies reports record sales in Q3 2026, driven by strong demand and strategic acquisitions in the printed circuit board industry.

Federal Home Loan Bank of Atlanta Issues Consolidated Obligations

Federal Home Loan Bank of Atlanta details issuance of consolidated obligations in recent filing, impacting the federally-sponsored credit agencies sector.

Full House Resorts plans permanent casino, seeks refinancing

Full House Resorts Inc. announces plans for a permanent casino in Waukegan, Illinois, while negotiating refinancing options for existing debt.

Integrated Rail & Resources Secures $944K in Preferred Stock Deal

Integrated Rail & Resources Inc. announces a $944,400 financing deal with Huntington Oil & Gas III, LLC to enhance operational capabilities.

Union Bankshares reports Q3 earnings, declares dividend

Union Bankshares Inc. announces Q3 earnings of $3.8 million and a quarterly dividend of $0.36 per share, highlighting strong financial performance.

Oceaneering reports Q3 2026 earnings; revenue up, income down

Oceaneering International Inc. reports mixed Q3 2026 results with revenue growth but a decline in net income, adjusting forecasts for future performance.

PUBLIC CO MANAGEMENT CORP Establishes New Series of Preferred Stock

PUBLIC CO MANAGEMENT CORP has filed to establish three new series of Preferred Stock, altering its capital structure and voting dynamics.

Securetech Innovations secures $10 million in financing deal

Securetech Innovations, Inc. has entered a $10 million financing agreement to support business development, impacting the motor vehicle parts industry.

CACI International amends by-laws, changes fiscal year end

CACI International Inc has amended its by-laws and changed its fiscal year end to December 31, signaling a strategic shift in governance.

Banner Corporation Reports Q3 Earnings, Declares Dividend

Banner Corporation announces Q3 2026 earnings of $47.7 million and a quarterly dividend of $0.52 per share, influenced by its recent acquisition.

FS Bancorp reports Q3 results, declares cash dividend

FS Bancorp, Inc. announces Q3 earnings drop and a cash dividend of $0.29 per share as it integrates Pacific West Bancorp.

Arbutus Biopharma Gains FDA Clearance for AB-101 Trials

Arbutus Biopharma announced FDA lifted clinical hold on AB-101, its oral PD-L1 inhibitor, allowing further trials. This could impact the hepatitis B treatment landscape.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →